Recent data do not provide evidence that resveratrol causes 'mainly negative' or 'adverse' effects on exercise training in humans

Journal of Physiology

Volumn 591, Issue 20, 2013, Pages 5251-5252

  Smoliga, James M ^a   Blanchard, Otis L ^b  

^a HIGH POINT UNIVERSITY   (United States)

^b Wilmore Labs LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PLACEBO; RESVERATROL; VASCULAR CELL ADHESION MOLECULE 1;

ANKLE BRACHIAL INDEX; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; EXERCISE; HUMAN; LETTER; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

CARDIOVASCULAR SYSTEM; EXERCISE; HUMANS; MALE; STILBENES;

EID: 84885403641     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.262956     Document Type: Letter

References (13)

1. Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ & Brenner DE (2010). Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: Safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 70, 9003-9011.
2. Drummond GB & Vowler SL (2012). Type I: families, planning and errors. J Physiol 590, 4971-4974.
3. Food and Drug Administration, U.S. Department of Health and Human Services (2005). Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. http://www.fda.gov/downloads/Drugs/Guidances/UCM078932.pdf
4. Gelman A & Stern H (2006). The difference between 'significant' and 'not significant' is not itself statistically significant. Am Stat 60, 328-331.
5. Gliemann L, Schmidt JF, Olesen J, Bienso RS, Peronard SL, Grandjean SU, Mortensen SP, Nyberg M, Bangsbo J, Pilegaard H & Hellsten Y (2013). Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J Physiol DOI: 10.1113/jphysiol.2013.258061
6. Huang G, Gibson CA, Tran ZV & Osness WH (2005). Controlled endurance exercise training and VO2max changes in older adults: a meta-analysis. Prev Cardiol 8, 217-225.
7. Nieuwenhuis S, Forstmann BU & Wagenmakers E-J (2011). Erroneous analyses of interactions in neuroscience: a problem of significance. Nat Neurosci 14, 1105-1107.
8. Seaman MA, Levin JR & Serlin RC (1991). New developments in pairwise multiple comparisons: some powerful and practicable procedures. Psychol Bull 110, 577-586.
9. Skrobuk P, von Kraemer S, Semenova MM, Zitting A & Koistinen HA (2012). Acute exposure to resveratrol inhibits AMPK activity in human skeletal muscle cells. Diabetologia 55, 3051-3060.
10. Smoliga JM, Colombo ES & Campen MJ (2013). A healthier approach to clinical trials evaluating resveratrol for primary prevention of age-related diseases in healthy populations. Aging (Albany NY) 5(7), 495-506.
11. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Rother J, Sievert H, van Sambeek M & Zeller T (2011). ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32, 2851-2906.
12. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD & Fowkes FG (2005). C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112, 976-983.
13. Yoshino J, Conte C, Fontana L, Mittendorfer B, Imai S, Schechtman KB, Gu C, Kunz I, Rossi Fanelli F, Patterson BW & Klein S (2012). Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab 16, 658-664.